Loading...

Roche Holding AG

RHHVFPNK
HealthcareDrug Manufacturers - General
$317.00
$4.27(1.37%)

Roche Holding AG RHHVF Peers

See (RHHVF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
RHHVF$317.00+1.37%256.1B25.32$12.52+3.47%
RHHBY$39.51+0.61%255.3B25.17$1.57+3.45%
RHHBF$328.00-3.24%247.6B26.16$12.54+3.28%
AZNCF$143.10-0.61%221.9B28.79$4.97+2.21%
NVSEF$110.25-1.82%209.2B17.28$6.38+3.59%
SNYNF$104.20+0.14%126.9B18.25$5.71+4.20%
BMYMP$790.00N/A95.6B3511.11$0.23+0.13%
CHGCY$26.07+0.93%85.8B29.97$0.87+0.93%
CHGCF$52.00-6.34%85.6B29.71$1.75+0.01%
GLAXF$19.00-2.36%77B18.45$1.03+4.26%
Showing 1 to 10 of 43 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

RHHVF vs RHHBY Comparison

RHHVF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RHHVF stands at 256.1B. In comparison, RHHBY has a market cap of 255.3B. Regarding current trading prices, RHHVF is priced at $317.00, while RHHBY trades at $39.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RHHVF currently has a P/E ratio of 25.32, whereas RHHBY's P/E ratio is 25.17. In terms of profitability, RHHVF's ROE is +0.35%, compared to RHHBY's ROE of +0.35%. Regarding short-term risk, RHHVF is less volatile compared to RHHBY. This indicates potentially lower risk in terms of short-term price fluctuations for RHHVF.

Stock Price Comparison

Loading...

Frequently Asked Questions